Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lymphomas

Clinical Trial at: Texas Oncology - Plano

SGN35-015:A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) in adults age 60 and above

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Hodgkins
USOR Number: 11282

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Head and Neck Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Plano

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Melanoma

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Renal Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Plano

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer (NRG-BR003)

  • Details

ClinicalTrials.gov ID: NCT02488967
Diagnosis Type: NA
USOR Number: 15146

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Oncology - Plano

A Multicenter, Open-Label Phase 1b/2 Trial of Lenvatinib (E7080) Plus Pembrolizumab in Subjects With Selected Solid Tumors (E7080-A001-111)

  • Details

ClinicalTrials.gov ID: NCT02501096
Diagnosis Type: NA
USOR Number: 15180

  • Practice Details

4708 Alliance Blvd, Suite 150
Plano, Texas 75093
287.97 mi. away
P: (972) 596-7801

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Breast Specialists - Plano

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

4716 Alliance Blvd, Suite 180
Plano, Texas 75093
287.97 mi. away
P: (972) 562-5999

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Breast Specialists - Plano

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

4716 Alliance Blvd, Suite 180
Plano, Texas 75093
287.97 mi. away
P: (972) 562-5999

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Breast Specialists - Plano

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

4716 Alliance Blvd, Suite 180
Plano, Texas 75093
287.97 mi. away
P: (972) 562-5999

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Texas Breast Specialists - Plano

A Phase 2, Open-label, Single-Agent, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects with Metastatic or Surgically Unresectable Urothelial Carcinoma Haboring FGF/FGFR Alterations

  • Details

ClinicalTrials.gov ID: NCT02872714
Diagnosis Type: NA
USOR Number: 15228

  • Practice Details

4716 Alliance Blvd, Suite 180
Plano, Texas 75093
287.97 mi. away
P: (972) 562-5999

More Details View Practice Page

Rectal Cancer

Clinical Trial at: Texas Oncology - Carrollton

A Phase 2 Study of INCMGA00012 in Participants With Squamous Carcinoma of the Anal Canal Who Have Progressed Following Platinum-Based Chemotherapy

  • Details

ClinicalTrials.gov ID: NCT03597295
Diagnosis Type: NA
USOR Number: 18134

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Carrollton

A Phase 2 Study of Poziotinib in Patients with Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, with EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20) (SPI-POZ-202)

  • Details

ClinicalTrials.gov ID: NCT03318939
Diagnosis Type: NSCLC
USOR Number: 17143

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

GI Stromal Tumor (GIST)

Clinical Trial at: Texas Oncology - Carrollton

An International, Multicenter, Open-label, Randomized, Phase 3 Study of BLU-285 vs Regorafenib in Patients with Locally Advanced Unresectable or Metastatic Gastrointestinal Stromal Tumor (GIST)

  • Details

ClinicalTrials.gov ID: NCT03465722
Diagnosis Type: NA
USOR Number: 18016

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Breast Cancer

Clinical Trial at: Texas Oncology - Carrollton

A randomized phase III trial comparing axillary lymph node dissection to axillary radiation in breast cancer patients (ct1-3 n1) who have positive sentinel lymph node disease after neoadjuvant chemotherapy (A011202)

  • Details

ClinicalTrials.gov ID: NCT01901094
Diagnosis Type: NA
USOR Number: 16076

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Lung Cancer

Clinical Trial at: Texas Oncology - Carrollton

Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non–Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib (2002)

  • Details

ClinicalTrials.gov ID: NCT03535740
Diagnosis Type: NSCLC
USOR Number: 18076

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Texas Oncology - Carrollton

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy - SGN22E-001

  • Details

ClinicalTrials.gov ID: NCT03219333
Diagnosis Type: NA
USOR Number: 17005

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Prostate Cancer

Clinical Trial at: Texas Oncology - Carrollton

A Phase 2, Randomized, Double-blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone with or without Abemaciclib in Patients with Metastatic Castration-Resistant Prostate Cancer (I3Y-MC-JPCM)

  • Details

ClinicalTrials.gov ID: NCT03706365
Diagnosis Type: NA
USOR Number: 18128

  • Practice Details

4352 N Josey Lane
Carrollton, Texas 75010
288.14 mi. away
P: (972) 394-4368

More Details View Practice Page

Pages